This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignees: Ucbbiopharma Srl, Sanofi, Ucb Biopharma Sprl. Active years: 2018-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 129 
1 out of 1,544 
1 out of 139 
Years Active: 2018-2020
Title: The Ingenious Contributions of Michael Louis Robert Deligny
Introduction
Michael Louis Robert Deligny is a notable inventor based in Brussels, Belgium, known for his significant contributions to the field of medicinal chemistry. With a total of four patents to his name, he has dedicated much of his career to developing innovative therapeutic compounds aimed at treating various human ailments.
Latest Patents
Deligny's recent patents reflect his commitment to addressing complex health challenges. One of his latest inventions, titled "Fused hexacyclic imidazole derivatives as modulators of TNF activity," involves substituted fused hexacyclic benzimidazole derivatives. These compounds are potent modulators of human TNFα activity, proving beneficial in the treatment and prevention of autoimmune and inflammatory disorders, neurological issues, pain-related conditions, cardiovascular diseases, metabolic disorders, ocular problems, and oncological concerns.
Another significant patent is "Fused pentacyclic imidazole derivatives as modulators of TNF activity." This series of substituted fused pentacyclic benzimidazole derivatives, along with their analogs, serves the same purpose as his other invention—modulating human TNFα activity to aid in the treatment of a variety of ailments mentioned above.
Career Highlights
Throughout his career, Michael Deligny has worked at esteemed companies such as UCB Biopharma Srl and UCB Biopharma Sprl. His roles at these organizations have allowed him to contribute extensively to innovative pharmaceutical developments and research initiatives.
Collaborations
In his professional journey, Deligny has collaborated with remarkable peers like Jag Paul Heer and Jean Keyaerts. These collaborations have enhanced his research and fostered a dynamic exchange of ideas within the field of medicinal chemistry.
Conclusion
Michael Louis Robert Deligny exemplifies the essence of innovation in the pharmaceutical industry. His impactful patents and collaborations demonstrate his dedication to improving human health through novel therapeutic solutions. As the field continues to evolve, Deligny’s contributions will undoubtedly leave a lasting legacy in the realm of medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile